Last reviewed · How we verify
NCT05092178
Calorie Restricted Diet and Exercise
NA trial testing calorie restricted diet and exercise in Metabolic Syndrome in 86 participants. Completed in 20 November 2022.
4 November 2021
Quick facts
| Lead sponsor | The First People's Hospital of Jingzhou |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 86 |
| Start date | 6 January 2019 |
| Primary completion | 4 November 2021 |
| Estimated completion | 20 November 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- calorie restricted diet and exercise
- exercise alone
Conditions studied
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
Sponsor
The First People's Hospital of Jingzhou
Who can join
Adults 35 to 70, any sex, with Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Calorie-restricted(CR) diet and exercise were effective to reduce Metabolic syndrome(MetS), however, its effect on knee functions for MetS patients with degenerate meniscus lesions(DMLs) was still poorly investigated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05092178
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Metabolic Syndrome
Currently open trials in the same condition.
- NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
- NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
- NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
Other The First People's Hospital of Jingzhou trials
Trials by the same sponsor.
- NCT06868004 — Holistic Nursing Benefits Cognitive and Psychiatric Symptoms in Alzheimer's Patients · NA · completed
- NCT05114694 — Early Arthroscopic Partial Meniscectomy(APM) · NA · unknown
- NCT04921202 — Metabolic Syndrome and Degenerative Meniscus Lesions Related Knee Function · completed
- NCT04837456 — Metabolic Syndrome and Degenerate Meniscus Tears · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05092178 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First People's Hospital of Jingzhou
- Last refreshed: 18 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05092178.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing